A 54-year-old female with chronic headache was admitted to our hospital because of hematochezia. She had routinely taken loxoprofen sodium because of severe headache. Emergent colonoscopic examination revealed ulceration of the cecum. After administration of loxoprofen sodium was discontinued and administration of sulfasalazine was initiated, her intestinal bleeding subsided. Twomonths after discontinuation of loxoprofen sodium, the colonoscopic examination revealed scar formation at the site of cecal ulceration. In this case, it was conceivable that the administration of loxoprofen sodium might have induced colonic ulceration. (Internal Medicine 38: 249-251, 1999) 
Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the classes of drugs which have been widely utilized to date. However, reports on the side effects of NSAIDshave increased with their widespread use. In particular, gastroduodenal mucosal damageis well knownas a complication of treatment using NSAIDs. For example, massive hemorrhage from gastric and duodenal ulcers or perforation during NSAIDtreatment have been reported (1) (2) (3) (4) . Recent studies have shown that long-term administration of NSAIDs results in inflammation of the small intestine and colon (5, 6) . The pathogenesis of the inflammation is not completely understood but it is thought to involve several interacting factors.
Loxoprofen sodium is one of the NSAIDs, which has been widely used in Japan. In this report, we describe a case of coIonic ulceration induced by administration of loxoprofen sodium.
For editorial comment, see also p 219.
Case Report
The patient, a 54-year-old female had, a history of chronic headache. She had taken loxoprofen sodium once or twice per day for a period of one year because of severe headache. On March 18, 1995, she suddenly noticed hematochezia but it was not accompanied by abdominal pain. Because the hematochezia continued, she cameto the emergencyroom of Nishi-Kobe Medical Center. Physical examination revealed no abnormalities. Laboratory test revealed the following: hemoglobin and hematocrit, 9.8 g/dl and 3 1.2%, respectively; white blood cell count, 3,000/jil; platelet count, 1.56xlO5/|il; total protein 6.0 g/dl; serum asparate transaminase, 16 IU//; serum alanine transaminase, 9 IU//; blood urea nitrogen (BUN), 7 mg/dl; and creatinine, 0.8 mg/dl. A lymphocyte stimulating test for loxoprofen sodium was negative. Viral and bacterial cultures of samples of her blood, urine, sputum and stool were negative. Onthe same day, endoscopic examination was performed. An upper endoscopic examination revealed no lesion which seemed to be bleeding. Colonoscopic examination revealed ulceration of the cecum (Fig. 1A) . Small intestinal radiography showed no abnormalities. Based on these findings, we concluded that the hematochezia was due to colonic ulceration. Microscopic expamination of biopsy specimen revealed nonspecific inflammation (Fig. 2 ). Histological and bacteriological examinations excluded Crohn's disease, vascular lesions and infectious disease including tuberculosis. Administration of loxoprofen sodium was discontinued and administration of sulfasalazine was initiated. Following discontinuation of loxoprofen sodium treatment, her intestinal bleeding subsided. Twomonths after discontinuation of loxoprofem sodium, a colonoscopic examination was performed. Endoscopic findings revealed scar forma- tion at the site of cecal ulceration (Fig. IB) . At present, this patient usually takes eperisone (Myonal) which is a muscle relaxant. She takes acetaminophen (0.5 g) and sulfasalazine (500 mg) only when she complains of severe headache. Since she discontinued loxoprofen sodium treatment, she has not experienced hematochezia.
Discussion
Ulceration of the upper gastrointestinal tract as a result of NSAIDtreatment is well known. Recently, the side effects of NSAIDson the distal small bowel and colon are increasingly being reported (7-13). We investigated a case of hematochezia due to cecal ulceration. In general, with reference to the differential diagnosis of cecal ulceration, simple ulcer, Behcet's disease, colonic tuberculosis, and Crohn's disease, are well known. In this case of hematochezia, blood, histological and bacteriological examination ruled out infectious disease (tuberculosis, cytomegalovirus, herpes virus, etc.) and Crohn's disease. The fact that the patient did not present with recurrent oral ulcer or genital ulceration or uveitis ruled out Behcet's disease. It is very difficult to distinguish cecal ulceration induced by NSAIDsfrom simple ulceration. However, in this case, discontinuation of loxoprofen sodiumrapidly resulted in disapperance of the hematochezia. Cecal ulceration has not recurred after the patient discontinued taking loxoprofen sodium. Although the lymphocyte stimulating test for loxoprofen sodiumwas negative, the clinical course of the hematochezia strongly indicated that this ulceration was induced by NSAIDs. The mechanismof NSAID-induced colonic ulceration may be related to the inhibition of intestinal prostaglandin synthesis. In the gut, prostaglandins have cytoprotective actions and various prostaglandins are synthesized by human colonic tissue. NSAIDsinhibit cyclo-oxygenase, thereby reducing prostaglandin production. Decreased prostaglandin synthesis may cause an increase in intestinal permeability, which would destroy local defense systems and allow entrance of bacteria into the mucosa, resulting in inflammatory infiltration. In addition, NSAIDsmay divert arachidonic acid toward the lipoxygenase pathway with resultant production of leukotrienes and free radi-Colonic Ulceration Induced by NSAIDs cals, thereby causing inflammation and tissue injury in the lower gut (4, 7).
Treatment of NSAID-induced colitis is reported to require only discontinuation of the offending agent. In this case, we treated our patient not only by rapidly discontinuing loxoprofen sodium administration but also by initiating sulfasalazine administration to accelerate the healing of colonic ulceration. Sulfasalazine inhibits the synthesis of lipoxygenase products and thromboxane B2 while enhancing the synthesis of prostaglandin E2 (14) . Bjarnason et al reported that there was a reduction in intestinal inflammation of patients with rheumatoid arthritis by administration of sulfasalazine (15, 16) . Therefore, in the case of NSAID-inducedcolitis, we must take into consideration that administration of sulfasalazine is one therapy.
Recently, Picot and colleagues reported the finding of two subtypes of cyclooxygenases (C0X1 and C0X2) (17) . COX1 is constitutive and C0X2is inducible. The former is found in platelets producing thromboxane 2 in the endothelium, producing prostacyclin in the stomach and producing prostaglandin E2, in the kidney. The latter is found in macrophages and in other cells that produce proteases, prostaglandins, and other inflammatory mediators. Therefore, if NSAIDswhich inhibit C0X2only are developed, NSAID-inducedside effects on the gut may be decreased. With the expected increase in the use of NSAIDsin the future, reports of NSAID-induced gastroenteropathy and complications thereof may increase. As we found in the present case, total colonscopy was very useful for examination of a patient complaining of hematochezia. Thus, in a patient with such a complaint of hematochezia, who has been receiving long-term administration of NSAIDs, it is advisable to carry out a colonoscopic examination to examinefor the presence of colonic ulcer or small intestinal ulcer.
